CPRX catalystpharma.com: Nilai perusahaan marang volume dodolan

Catalyst Pharmaceuticals, Inc. (CPRX) - logo korporat

Catalyst Pharmaceuticals (CPRX) is integrating ESG principles into the production of neurological drugs to ensure ethical testing. Its monopoly status in the treatment of muscle pathologies allows the company to exercise significant pricing power. The current EV/Sales ratio reflects the business valuation trend, where the 5196.04 metric determines this level. The hyper-profitable sales stage of innovative treatments is restoring mobility to patients with Lambert-Eaton syndrome.

Catalyst Pharmaceuticals Inc - Multiplikator EV/Sales CPRX (periode 23.11.2025 - 25.07.2026)

CPRX (Catalyst Corp): rincian analitis lan laporan miturut indikator

Pambiji fundamental perusahaan:CPRX - Catalyst Pharmaceuticals
Sampel barang Catalyst Pharmaceuticals Inc

This indicator determines the enterprise value of the entire business, including net debt, and compares it to sales volume to identify the degree of asset overvaluation. By analyzing the enterprise value-to-revenue trend, an investor can see the monetization efficiency of Catalyst Pharmaceuticals (CPRX) patents for rare neuromuscular disease therapies, which allows for an assessment of the company's fundamental stability amid price fluctuations.

Analisis pesaing Catalyst Pharmaceuticals

BIIB (Biogen Inc.) - Rasio nilai perusahaan marang pendapatan|NBIX: Multiplikator EV/Sales|RGC (Regencell Bioscience Holdings Limited) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Axsome Therapeutics Inc|ACAD: Nilai bisnis marang pendapatan|Multiplikator EV/Sales XENE|Multiplikator EV/Sales vikingtherapeutics.com (VKTX)|Rasio nilai perusahaan marang pendapatan Supernus SUPN|DNLI (Denali Therapeutics Inc.) - Nilai perusahaan marang volume dodolan|Harmony Corp - Multiplikator EV/Sales|BHVN: Rasio nilai perusahaan marang pendapatan|AMLX: Multiplikator EV/Sales|TRVI: Koefisien nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Praxis Medicines|Multiplikator nilai perusahaan marang pendapatan Anavex AVXL|Rasio nilai perusahaan marang pendapatan CeriBell Corp (CBLL)|Koefisien nilai perusahaan marang pendapatan PRTA|Multiplikator EV/Sales ALEC (Alector)|Annexon (ANNX) - Multiplikator nilai perusahaan marang pendapatan|OMER - Rasio nilai perusahaan marang pendapatan|NGNE (Neurogene) - Rasio nilai perusahaan marang pendapatan|ACIU: Multiplikator EV/Sales|VYGR - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Neumora Therapeutics, Inc.|Rasio nilai perusahaan marang pendapatan SCLX (Scilex)|Nilai perusahaan marang pendapatan TVGN (Tevogen Bio)|Multiplikator EV/Sales Alpha Cognition Inc (ACOG)|Multiplikator EV/Sales CGTX (cogrx.com)|Rasio total nilai perusahaan marang pendapatan Inhibikase Pharma (IKT)|SAVA: Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Assertio ASRT|COYA (coyatherapeutics.com) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan VTGN|OVID (Ovid Therapeutics) - Multiplikator EV/Sales|Acumen Pharmaceuticals, Inc (ABOS) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan CervoMed, Inc. (CRVO)|ATHE - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales CLNN (Clene Inc.)|Rasio total nilai perusahaan marang pendapatan PepGen Inc. (PEPG)|JUNS - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Relmada Corp|ANVS (Annovis Bio, Inc.) - Nilai perusahaan marang pendapatan|Grace Tx (GRCE) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan AIFF|Multiplikator EV/Sales anewmeds.com|Rasio nilai perusahaan marang pendapatan NeuroSense Therapeutics (NRSN)|RVPH (Reviva Pharmaceuticals Holdings) - Nilai bisnis marang pendapatan|MetaVia - Nilai perusahaan marang pendapatan|NRXS: Rasio nilai perusahaan marang pendapatan|Helius Medical Technologies, Inc. - Multiplikator EV/Sales|PASG: Rasio nilai perusahaan marang pendapatan|Neuphoria (NEUP) - Rasio nilai perusahaan marang pendapatan|Minerva Neurosciences - Nilai bisnis marang pendapatan|ATHA (Athira Pharma, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan addextherapeutics.com ADXN|Nilai perusahaan marang pendapatan ALZN (Alzamend Neuro Inc.)|CYCN (Cyclerion Therapeutics, Inc.) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales PTIX (Protagenic)|Multiplikator EV/Sales pasitheaclinics.com KTTA|CRGT - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan ATXI (Avenue Therapeutics)|BCLI: Multiplikator EV/Sales|Cara Therapeutics - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Chromocell Therapeutics Corporation|Multiplikator EV/Sales Eliem Therapeutics Inc.|Rasio nilai perusahaan marang pendapatan Intra-Cellular Therapies, Inc. (ITCI)|LBPH (Longboard Pharmaceuticals) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales MRNS (marinuspharma.com)|NKGN: Rasio nilai perusahaan marang pendapatan|NRBO - Rasio nilai perusahaan marang pendapatan|SAGE - Multiplikator EV/Sales|Synaptogenix (SNPX) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Trevena (TRVN)|Nilai perusahaan marang pendapatan VIGL|Rasio nilai perusahaan marang pendapatan WENA (Anew Medical)|Multiplikator EV/Sales CERE